Lankenau Institute for Medical Research

Lankenau Institute for Medical Research

About the Lankenau Institute for Medical Research

At Lankenau Institute for Medical Research (LIMR) we study and seek remedies for cancer as well as cardiovascular, autoimmune, gastrointestinal and other diseases. Our research is at the leading edge of today’s immunotherapy revolution in health care. Our guiding principle: In medicine, hope springs from research.

Featured Research

Results from an early trial by a company with ties to the Lankenau Institute for Medical Research offer hope that a potent form of attack against metastatic prostate cancer is on the horizon. Charles J. Link, MD; Jonathan Lewis, MD; and George Prendergast, PhD, President and CEO of LIMR, are spearheading the effort.



The Lankenau Institute for Medical Research's signature ACAPRENEURIAL™ model focuses on invention, intellectual property and new company development, with a secondary goal of pursuing new academic knowledge.

Closeup of researcher placing slide on microscope

Support LIMR

Your contributions to LIMR help accelerate our ability to bring research from the laboratory to the patient.